Presentation Information

[[OD]1S10a-4]Mechanisms and treatments for disorders caused by abnormal activation of the type 2 ryanodine receptor (RyR2)

Nagomi Kurebayashi (Dept Pharmacol, Juntendo Univ Fac Med)

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in